Eureka Therapeutics Competitors and Similar CompaniesClear all
Eureka Therapeutics's competitors and similar companies include Immatics and Oncologie.
 Eureka Therapeutics Eureka Therapeutics is a biotechnology company focused on discovery of novel antibody immunotherapies for the treatment of cancer.
|  Immatics Immatics is a biotechnology company that is primarily engaged in the research and development of T cell redirecting immunotherapies for the treatment of cancer. | ||
Founding Date | Founding Date 2006 | Founding Date N/A | Founding Date 2018 |
Type | Type Private | Type Public | Type Private |
Tags | |||
Locations | Locations Emeryville, US HQ | Locations Tübingen, DE HQ Frankfurt Am Main, DE München, DE Houston, US | Locations Waltham, US HQ Shanghai, CN Boston, US |
Employees | Employees 432% decrease | Employees 29723% increase | Employees 8 |
Funding | |||
Latest funding round | Latest funding round $ 45m (over 6 years ago) | Latest funding round N/A | Latest funding round $ 80m (about 7 years ago) |
Total funding raised | Total funding raised $ 130.4m | Total funding raised $ 267.3m | Total funding raised $ 96.5m |
For sources of this data, please see the company profile
View Company Profiles
Immatics
HQ
Tübingen, DE
Employees
297↑ 23% increase
Immatics is a biotechnology company that is primarily engaged in the research and development of T cell redirecting immunotherapies for the treatment of cancer.
View company